Immunology Program

The Ming Li Lab

Research

Ming Li, PhD

The pervasive influence of the immune system on human health and disease underscores the importance of mechanistic understanding of immune regulation under pathophysiological conditions. Modern immunology is built on the foundation of clonal selection and pattern recognition theories that emphasize innate and adaptive immune recognition in controlling immune responses.

View Lab Overview

Featured News

Sloan Kettering Institute Scientists Solve a 100-Year-Old Mystery about Cancer

Thursday, January 21, 2021

Scientists have long known that cancer cells and immune cells have an uncommon hunger for glucose but haven’t understood why. A new study offers an answer.

In the Lab

MSK-led Studies Support the Concept of “Cancer Environment Immunotherapy”

Wednesday, October 21, 2020

Targeting the cancer environment, rather than the cancer itself, could be a new avenue for immunotherapy.

At Work: Immunologist Ming Li

Immunologist Ming Li hopes to uncover insights that would allow scientists to harness the power of the immune system for cancer therapy.

View All Featured News

Publications

K. Xu, N. Yin, M. Peng, E.G. Stamatiades, A. Shyu, P. Li, X. Zhang, M.H. Do, Z. Wang, K.J. Capistrano, C. Chou, A.G. Levine, A.Y. Rudensky, M.O. Li. Glycolysis Fuels Phosphoinositide 3-Kinase Signaling to Bolster T Cell Immunity. Science 2021, 371: 405-410.

S. Li, M. Liu, M.H. Do, C. Chou, E.G. Stamatiades, B.G. Nixon, W. Shi, X. Zhang, P. Li, S. Gao, K.J. Capistrano, H. Xu, N.V. Cheung, M.O. Li. Cancer Immunotherapy via Targeted TGF-beta Signaling Blockade in T_H Cells. Nature 2020, 587: 121-125.

View All Publications

People

Ming Li, PhD

Immunologist Ming Li studies mechanisms of immune regulation, and their relevance to diseases including cancer.
PhD, Columbia University

lim@mskcc.org: Email Address
646-888-2371: Office Phone

Members

Alexandra Ramadhin
Administrative Assistant II

Xijian Xu

Research Associate

Lab Alumni

Saida Dadi, PhD — Saida Dadi
Research Fellow

Chong Luo
Associate Director at Tome Biosciences, Cambridge, MA

Soyoung Oh, PhD — Soyoung Oh
Research Fellow

Min Peng, PhD — Min Peng
Research Fellow

Omar Beckett

Research Technician

Chun Chou, Research Fellow — Chun Chou
Research Fellow

Sophia Gonzalez

Administrative Assistant II

Ilona Gutcher

Research Fellow

Davina Kang

Lab Technician

Abira Sarkar

Research Fellow

Wei Shi, Research Scholar — Wei Shi
Research Scholar

Weiming Ouyang, PhD — Weiming Ouyang
Research Associate

Lab Affiliations

Achievements

Howard Hughes Medical Institute Faculty Scholar (2016)
AAI-BD Biosciences Investigator Award for Outstanding Contributions to the Field of Immunology (2016)
Scholar, Leukemia and Lymphoma Society (2014)
Louise and Allston Boyer Young Investigator Award for Basic Research (2012)
Scholar, American Cancer Society (2012)

Scholar, Rita Allen Foundation (2008)

Open Positions

To learn more about available postdoctoral opportunities, please visit our Career Center

Career Opportunities

Apply now

Get in Touch

lim@mskcc.org

Lab Head Email
646-888-2371

Office Phone
646-422-0502

Office Fax

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Ming Li discloses the following relationships and financial interests:

Amberstone Biosciences Inc.
Ownership / Equity Interests; Provision of Services
Leap Therapeutics Inc.
Provision of Services

Tango Therapeutics
Provision of Services

The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.

This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at ecoi@mskcc.org.

View all disclosures